Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Ulrich Bogdahn, MD
Woman and Man Max 99 years
Ulrich Bogdahn, MD, Prof
Update Il y a 4 ans
Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
Glioblastomas represent 40% of all tumors of the central nervous system (CNS) and are among the most lethal tumors. Temozolomide (TMZ) combined with radiotherapy was the first substance to...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Ulrich Bogdahn, MD
Update Il y a 4 ans
Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma
In this multinational dose finding Phase IIb study the efficacy and safety of two doses of AP 12009 compared to standard chemotherapy (temozolomide or PCV) is investigated in adult patient...
Country
Austria
,
Georgia
,
Germany
,
India
,
Israel
,
Russian Federation
organs
None
Specialty
None
Closed trial
More information